Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | MITF | O75030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL16628638 | 0.97 | ALDH1A1 (0.42) | ALDH1A1KDM4EMEN1KMT2AGAA | |
| SCHEMBL16628502 | 0.97 | ALDH1A1 (0.42) | ALDH1A1KDM4EMEN1KMT2AGAA | |
| SCHEMBL16628630 | 0.97 | ALDH1A1 (0.42) | ALDH1A1KDM4EMEN1KMT2AGAA | |
| SCHEMBL16628405 | 0.84 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| SCHEMBL16628535 | 0.80 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| SCHEMBL10786755 | 0.80 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| Zinc Ion SCHEMBL11581561 | 0.80 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| SCHEMBL16628473 | 0.80 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| Potassium Ion SCHEMBL16628603 | 0.80 | SIGMAR1 (0.47) | ALDH1A1KDM4EKMT2AMAPTSIGMAR1 | |
| SCHEMBL16628641 | 0.79 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860170-B1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL IND LTD (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-9670129-B2 | Process for preparing 4-hydroxybutyl acrylate | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2015-05-07 | — | — | US | disclosed |
| EP-2860170-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | Osaka Organic Chemical Ind., Ltd. (JP) | 2015-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | LTB4R2, LTA4H, LTB4R | ALDH1A1 261/4885KDM4E 3193/4885MEN1 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.